CCPortal
DOI10.1016/j.aquatox.2017.01.001
Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone
Davis, J. M.1,3; Ekman, D. R.1; Skelton, D. M.1,4; LaLone, C. A.2; Ankley, G. T.2; Cavallin, J. E.2; Villeneuve, D. L.2; Collette, T. W.1
发表日期2017-03-01
ISSN0166-445X
卷号184页码:103-115
英文摘要

One objective in developing adverse outcome pathways (AOPs) is to connect biological changes that are relevant to risk assessors (i.e., fecundity) to molecular and cellular-level alterations that might be detectable at earlier stages of a chemical exposure. Here, we examined biochemical responses of fathead minnows (Pimephales promelas) to inform an AOP relevant to spironolactone's activation of the androgen receptor, as well as explore other biological impacts possibly unrelated to this receptor. Liquid chromatography with high resolution mass spectrometry (LC-MS) was used to measure changes in endogenous polar metabolites in livers of male and female fish that were exposed to five water concentrations of spironolactone (0, 0.05, 0.5. 5, or 50 mu g L-1) for 21 days. Metabolite profiles were affected at the two highest concentrations (5 and 50 mu g L-1), but not in the lower-level exposures, which agreed with earlier reported results of reduced female fecundity and plasma vitellogenin (VTG) levels. We then applied partial least squares regression to assess whether metabolite alterations covaried with changes in fecundity, VTG gene expression and protein concentrations, and plasma 17 beta-estradiol and testosterone concentrations. Metabolite profiles significantly covaried with all measured endpoints in females, but only with plasma testosterone in males. Fecundity reductions occurred in parallel with changes in metabolites important in osmoregulation (e.g., betaine), membrane transport (e.g., L-carnitine), and biosynthesis of carnitine (e.g., methionine) and VTG (e.g., glutamate). Based on a network analysis program (i.e., mummichog), spironolactone also affected amino acid, tryptophan, and fatty acid metabolism. Thus, by identifying possible key events related to changes in biochemical pathways, this approach built upon an established AOP describing spirono-lactone's androgenic properties and highlighted broader implications potentially unrelated to androgen receptor activation, which could form a basis for the development of an AOP network. Published by Elsevier B.V.


英文关键词Metabolomics;Fathead minnow;Mineralocorticoid;Reproduction
语种英语
WOS记录号WOS:000395608900009
来源期刊AQUATIC TOXICOLOGY
来源机构美国环保署
文献类型期刊论文
条目标识符http://gcip.llas.ac.cn/handle/2XKMVOVA/57798
作者单位1.US EPA, Natl Exposure Res Lab, 960 Coll Stn Rd, Athens, GA 30605 USA;
2.US EPA, Natl Hlth & Environm Effects Res Lab, 6201 Congdon Blvd, Duluth, MN 55804 USA;
3.US EPA, Water Protect Div, Reg 4,61 Forsyth St SW, Atlanta, GA 30303 USA;
4.US FDA, 6751 Steger Dr, Cincinnati, OH 45237 USA
推荐引用方式
GB/T 7714
Davis, J. M.,Ekman, D. R.,Skelton, D. M.,et al. Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone[J]. 美国环保署,2017,184:103-115.
APA Davis, J. M..,Ekman, D. R..,Skelton, D. M..,LaLone, C. A..,Ankley, G. T..,...&Collette, T. W..(2017).Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone.AQUATIC TOXICOLOGY,184,103-115.
MLA Davis, J. M.,et al."Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone".AQUATIC TOXICOLOGY 184(2017):103-115.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Davis, J. M.]的文章
[Ekman, D. R.]的文章
[Skelton, D. M.]的文章
百度学术
百度学术中相似的文章
[Davis, J. M.]的文章
[Ekman, D. R.]的文章
[Skelton, D. M.]的文章
必应学术
必应学术中相似的文章
[Davis, J. M.]的文章
[Ekman, D. R.]的文章
[Skelton, D. M.]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。